FdaApplication
ANDA 202766
Identifiers
- fda_app_no: ANDA202766
Properties
| Property | Value |
|---|---|
| applicant_name | XELLIA PHARMACEUTICALS APS |
| application_type | ANDA |
| approval_date | 2014-01-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POLYMYXIN B SULFATE | POLYMYXIN B SULFATE | EQ 500,000 UNITS BASE/VIAL | INJECTABLE;INJECTION |
1 product